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Despite	   remarkable	   successes	   in	   the	   treatment	   of	   breast	   cancer,	   some	   challenges	   remain.	  Gold	  
nanoparticles	   may	   prove	   valuable	   in	   addressing	   these	   problems	   owing	   to	   their	   unique	  
characteristics	   that	   make	   them	   elective	   agents	   for	   the	   conjugation	   with	   drugs	   and	   for	  
photothermal	   therapy	  [1].	  The	  potential	   toxicity	   of	   AuNPs	   remains	   a	  major	   hurdle	   that	   impedes	  
their	  use	  in	  clinical	  settings.	  In	  this	  study,	  stable	  and	  biocompatible	  colloidal	  AuNPs	  (4-­‐10	  nm)	  were	  
obtained	   by	   their	   functionalization	   with	   biocompatible	   stabilizing	   polymers	   (polyamidoamines,	  
PAA).	   Sequentially,	   coated-­‐AuNPs	  were	  used	  as	  platform	   for	   the	   conjugation	  of	   anticancer	  drugs	  
(Fig.	  1).	  AuNPs	  were	  conjugated	  with	  Herceptin,	  a	  chemotherapic	  agent	  used	  to	  treat	  breast	  cancer	  
and	  their	  efficacy	  was	  evaluated	  in	  vitro.	  Two	  breast	  cancer	  cell	  lines	  were	  used	  (SKBR-­‐3	  and	  MCF-­‐
7)	   and	   compared	   with	   fibroblast-­‐like	   cell	   line	   (NIH-­‐3T3).	   Preliminary	   biological	   investigation	  
showed	   that	   polymer	   coated-­‐AuNPs	   functionalized	  with	   Herceptin	   led	   to	   increased	   efficacy	   and	  
specificity	  for	  target	  cells	   in	  comparison	  with	  free	  drug	  and	  uncoated	  AuNPs,	  consistent	  with	  the	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